A clinical trial to study the effect of Virechan karma in Prediabetes in Overweight people.

A randomized controlled clinical trial of efficacy of Virechan karma on Insulin Resistance with Special Reference to Santarpanjanya Vikar(Medorog) - RCVKIR

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029248

Enrollment

Registered

2020-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Virechan karma: Virechan Karma with Danti leha 10gm Duration -1 day Control Intervention1: Diet and exercise: Diet plan 17 days. Energy 20 k cal / kg IBW not 1000 K cal / day Carboh

Eligibility

Inclusion criteria

Inclusion criteria: HOMA IR > 2 BMI >23 to 27.9

Exclusion criteria

Exclusion criteria: Patient who are not willing for treatment Patient in critical condition Pregnant women Virechan ayogya

Design outcomes

Primary

Measure	Time frame
Reduction of Homa-IRTimepoint: 17days	—

Secondary

Measure	Time frame
To see the effect of virechana karm on haematological parameter Serum Insulin,BSL (blood sugar level) fasting and post prandial]Timepoint: 17days	—

Countries

India

Contacts

Public ContactVd Vishwas Gogate

Government Ayurved college and Hospital Nanded

vishwas_eknath@yahoo.co.in9422214311

Outcome results